Diyabet Yönetiminde Farklı Bir Boyut: İnsülin Pompa Tedavisi ve Hemşirelerin Sorumlulukları
Özet
İnsülin pompası tedavisi, tip 1 ve tip 2 diyabet yönetiminde yaşam kalitesini ve glisemik kontrolü artıran, hipoglisemi ile akut/kronik komplikasyonları azaltan esnek bir yöntemdir. Cihaz, vücuda 24 saat boyunca özelleştirilmiş dozlarda hızlı etkili insülini bazal ve bolus olarak iletir. Pompa tedavisi yaş sınırı olmaksızın cihazı yönetebilecek, sık hipoglisemi yaşayan veya hamilelik planlayan bireyler için uygundur. Geleneksel, patch, mikro, implante ve çift hormonlu olmak üzere farklı türleri bulunan bu teknoloji; yaşam biçiminde esneklik sağlama gibi avantajlarının yanında tıkanma, enfeksiyon ve diyabetik ketoasidoz (DKA) riski gibi komplikasyonlar da barındırır. Tedavinin başarısında veri analizi sağlayan karar destek sistemleri ve karbonhidrat sayımı kritik öneme sahiptir. Diyabet hemşireleri; hastaların evde ve hastanede pompayı güvenli yönetmesi, teknik becerileri kazanması, komplikasyon takibi ve pompanın çıkarılması gereken durumlarda alternatif insülin rejimlerinin uygulanması süreçlerinde eğitim ve izlemden sorumludur. Sonuç olarak insülin pompası, hasta seçimi doğru yapıldığında ve uzman ekip desteğiyle yürütüldüğünde diyabet yönetiminde başarı oranı yüksek bir seçenektir.
Insulin pump therapy is a flexible method in type 1 and type 2 diabetes management that improves quality of life and glycemic control while reducing hypoglycemia and acute/chronic complications. The device delivers fast-acting insulin to the body 24 hours a day in customized basal and bolus doses. Pump therapy is suitable for individuals of all ages who can manage the device, experience frequent hypoglycemia, or plan a pregnancy. This technology, which has different types such as traditional, patch, micro, implantable, and dual-hormone, offers advantages like lifestyle flexibility but also carries complications such as occlusion, infection, and diabetic ketoasidoz (DKA) risks. Decision support systems providing data analysis and carbohydrate counting are critical to the success of the treatment. Diabetes nurses are responsible for education and monitoring regarding patients' safe management of the pump at home and in the hospital, acquiring technical skills, complication tracking, and implementing alternative insulin regimens when the pump needs to be removed. Consequently, the insulin pump is a highly successful option in diabetes management when appropriate patient selection is made and conducted with specialist team support.
Referanslar
Nimri R, Nir J, Phillip M. Insulin pump therapy. American Journal Of Therapeutics. 2020;27(1), 30-41. doi: 10.1097/MJT.0000000000001097
Sora ND, Shashpal F, Bond EA, Jenkins AJ. Insulin pumps: review of technological advancement in diabetes management. The American Journal of the Medical Sciences. 2019;358(5):326-331. doi:10.1016/j.amjms.2019.08.008
Leonhardi BJ, Boyle ME, Beer KA, et al. Use of continuous subcutaneous insulin infusion (insulin pump) therapy in the hospital: a review of one institution’s experience. Journal of Diabetes Science and Technology. 2008;2(6):948-62.
American Diabetes Association (ADA). Who Should Use a Pump 2022. (14.06.2022 tarihinde https://www.diabetes.org/tools-support/devices-technology/who-should-use-a-pump adresinden ulaşılmıştır).
American Diabetes Association (ADA). Standards of medical care in diabetes-2021. Diabetes Care. 2021; 44 (Supplement 1), 85-99. doi: 10.2337/dc21-ad09b
Hatun Ş, Yeşiltepe MG, Eviz E. Otomatik insülin verme sistemleri/yapay pankreas (Minimed 780g) uygulama rehberi. Koç Üniversitesi Tıp Fakültesi Çocuk Endokrinoloji ve Diyabet Bilim Dalı. 2021.
De Oliveira Loureiro T, Cardoso JN, Lopes CDPL. The effect of insulin pump therapy in retinal vasculature in type 1 diabetic patients. European Journal of Ophthalmology. 20211;31(6): 3142-3148. doi.org/10.1177/1120672121990576
Rai I, Wanjai A, Acharya S. Recent advances in ınsulin delivery devices and modes of ınsulin therapy. Journal of Pharmaceutical Research International. 2021;33(57B): 358-367.
Kandemir N, Özön ZA, Gönç EN. İnsülin pompası tedavi kılavuzu. Ankara, 2006.
Ross PL, Milburn J, Reith DM. Clinical review: insulin pump-associated adverse events in adults and children. Acta Diabetologica. 2015;52 (6), 1017-1024. doi: 10.1007/s00592-015-0784-2
Karges B, Schwandt A, Heidtmann B, et al. Association of ınsulin pump therapy vs ınsulin ınjection therapy with severe hypoglycemia, ketoacidosis, and glycemic control among children, adolescents, and young adults with type 1 diabetes. Jama. 2017;318(14):1358-1366. doi: 10.1001.
Berget C, Messer LH, Forlenza GP. A clinical overview of insulin pump therapy for the management of diabetes: past, present, and future of intensive therapy. Diabetes Spectrum. 2019;32 (3), 194-204. doi: 10.2337/ds18-0091
Kamecke, U, Waldenmaier, C D Haug, et al. Freckmann, “Establishing methods to determine clinically relevant bolus and basal rate delivery accuracy of insulin pumps.” Journal of Diabetes Science and Technology. 2019;13(1), 60-67.
Wolff MK. Comparison of various ınsulin pumps with respect to accuracy of the ınsulin delivery. MS Thesis. NTNU. 2021.
Tütüncüler F, Kendirci Peltek HN, Buluş D ve ark. İnsülin tedavisi ve uygulanması. Aycan Z (ed.) Çocukluk Çağı Diyabeti Eğitimci Rehberi. ISBN: 978-975-590-778-9, Ankara.
Wheeler BJ, Collyns OJ, Meier RA, et al. Improved technology satisfaction and sleep quality with Medtronic MiniMed® advanced hybrid closed-loop delivery compared to predictive low glucose suspend in people with type 1 diabetes in a randomized crossover trial. Acta Diabetol. 2022;59(1): 31-37 doi: 10.1007/s00592-021-01789-5.
Heinemann L, Waldenmaier D, Kulzer B, Ziegler R, Ginsberg B, Freckmann G. Patch pumps: are they all the same?. Journal of Diabetes Science and Technology 2019;13(1):34-40. doi:10.1177/1932296818795150
Insulin Pumpers (06.08.2022 tarihinde http://www.insulin-pumpers.org/faq/setspots.shtml adresinden ulaşılmıştır).
İnsulin Pump Awareness Group (İPAG). (06.08.2022 tarihinde https://www.ipag.co.uk/next-step-to-artificial-pancreas-670g-is-fda-approved/ adresinden ulaşılmıştır).
Medtronic. İnsülin Pompa Sistemleri 2022a. (14.06.2022 tarihinde https://www.medtronicdiabetes.com adresinden ulaşılmıştır).
Medtronic, İnsülin Pompa Sistemleri 2022b. (14.06.2022 tarihinde https://www.medtronicdiabetes.com/products/minimed-630g-insulin-pump-system adresinden ulaşılmıştır).
Medtronic, İnsülin Pompa Sistemleri 2022c. (14.06.2022 tarihinde https://www.medtronicdiabetes.com/products/minimed-770g-insulin-pump-system adresinden ulaşılmıştır).
LeMed Salus. Omnipod DASH® Nasıl Kullanılır? 2022. 14.06.2022 tarihinde https://medsalus.com.tr/omnipod-nasil-kullanilir/ adresinden ulaşılmıştır).
Bally L, Thabit H, Hovorka R. Finding the right route for insulin delivery–an overview of implantable pump therapy. Expert Opinion on Drug Delivery. 2017;14(9), 1103-1111. doi: 10.1080/17425247.2017.1267138
Healthline. 2022. (14.06.2000 tarihinde https://www.healthline.com/diabetesmine/implantable-insulin-pumps#Implantable-Insulin-Pumps,-The-Basics adresinden ulaşılmıştır).
Cinar A. Automated ınsulin delivery algorithms. Diabetes Spectrum. 2019;32(3), 209-214. doi: doi.org/10.2337/ds18-0100
Nimri R, Dassau E, Segall T, et al. Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: variations among countries and physicians. Diabetes, Obesity and Metabolism. 2018;20(10):2458-2466. doi:10.1111/dom.13408
Rezni, Y, Cohen O, Aronson R. Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial. The Lancet. 2014; 384(9950), 1265-1272. Doi: 10.1016/S0140-6736(14)61037-0.
Landau Z, Raz I, Wainstein J. The role of insulin pump therapy for type 2 diabetes mellitus. Diabetes/Metabolism Research and Reviews. 2017;33(1), 2822. doi: 10.1002/dmrr.2822
Diyabetes Mellitus Çalışma ve Eğitim Grubu. (TEMD). Diyabetes Mellitus Tanı, Tedavi ve İzlem Kılavuzu (2020). SBN 978-605-4011-40-7, Ankara.
Gosden CJ, Winocour P. Diabetes specialist nurses and role evolvement: a survey by Diabetes UK and ABCD of specialist diabetes services 2007. Diabetic Medicine. 2009;26 (5), 560-565.
American Nurse Association. (14.06.2011 tarihinde https://www.myamericannurse.com/boost-confidence-caring-patients-insulin-pumps/ adresinden ulaşılmıştır).
Umpierrez GE, Klonoff DC. Diabetes technology update: use of ınsulin pumps and continuous glucose monitoring in the hospital. Diabetes Care. 2018;41(8):1579-1589. doi:10.2337/dci18-0002
Evans K. Insulin pumps in hospital: a guide for the generalist physician. Clinical Medicine. 2013;13(3):244-7.
Sherr LJ, Tahuschmann M, Battelino T, et al. ISPAD Clinical practice consensus guidelines 2018: diabetes technologies. Pediatric Diabetes. 19:302-325. doi: 10.1111/pedi.12731.
